Inhibition of SARS-CoV-2 infection by Porphyromonas gingivalis and the oral microbiome
A. Bontempo, A. Chirino, A. Heidari, A. Lugo, S. Shindo, M. R. Pastore, S. Antonson, C. Godoy, F. Nichols, J. Potempa, M. Davey, T. Kawai, M. Cayabyab
This study shows that Porphyromonas gingivalis and other oral bacteria can inhibit SARS-CoV-2 infection through cytotoxicity and unknown mechanisms, with individual variation in oral microbiome activity.
bioRxiv · Feb 27, 2024 · PreprintMicrobiology